Detailed Segmentation:
Global Anticonvulsant Drugs Market, By Drug Class (Revenue, USD Mn, 2021 - 2033)
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
Global Anticonvulsant Drugs Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)
- Enteral
- Parenteral
Global Anticonvulsant Drugs Market, By Indication (Revenue, USD Mn, 2021 - 2033)
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
Global Anticonvulsant Drugs Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Anticonvulsant Drugs Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- U.S.
- Canada
- By Drug Class
- Latin America
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Drug Class
- Europe
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Drug Class
- Asia Pacific
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Drug Class
- Middle East
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country
- GCC
- Israel
- Rest of Middle East
- By Drug Class
- Africa
- By Drug Class
- Barbiturates
- Benzodiazepines
- Aromatic allylic alcohols
- Carboxamides
- Triazine
- AMPA receptor antagonists
- Carbamate
- Hydantoin
- Fatty Acid Derivative
- GABA analogs
- Valproylamides
- Others (Propionates, Oxazolidinediones, etc.)
- By Route of Administration
- Enteral
- Parenteral
- By Indication
- Epilepsy
- Neuropathic pain
- Anxiety
- Fibromyalgia
- Bipolar Disorder
- Others (Borderline personality disorder, etc.)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Drug Class
- North America
Company Profiles
- Novartis AG
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GSK plc.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Zogenix
- Dr. Reddy’s Laboratories Ltd.
- Alkem Labs
- SK BIOPHARMACEUTICALS
- Eisai Co., Ltd
- Angelini S.p.a.
- Sun Pharmaceutical Industries Ltd.
- UCB S.A.
- Unichem Laboratories
- Jazz Pharmaceuticals, Inc.
- Neuropathix, Inc.
- Xenon Pharmaceuticals, Inc.
- SK Life Science, Inc.
- Sumitomo Pharma Co., Ltd
- Bausch Health Companies Inc.
- Novartis AG
“*” marked represents similar segmentation in other categories in the respective section.